Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanthanum Carbonate for Hyperphosphatemia in Hemodialysis Patients
NCT00769496Phase 2Completed
- Sponsor
- Bayer
- Start
- Jan 2005
- Primary completion
- May 2008
- Countries
- 1
01
Overview
A Phase 2 trial of lanthanum carbonate in hyperphosphatemia, sponsored by Bayer. Started Jan 2005; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00769496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00769496.